by Indigo | Aug 1, 2023 | 2023, News
Indigo has secured its position among the top 10 most promising MedTech companies in the region. This recognition comes as Flanders continues to foster a vibrant ecosystem for startups, propelled by initiatives like Startup.Flanders. Supported by Flanders Investment...
by Indigo | Jun 19, 2023 | 2023, News
This year’s ADA (American Diabetes Association) conference in sunny San Diego (June 23-26, 2023) promises to be an exceptional event as industry leaders, Key Opinion Leaders, fellow researchers, and industry partners converge for collaboration and innovation!...
by Indigo | May 15, 2023 | 2023, News
Arun is an award-winning engineer who brings over 15 years’ experience in leading the design and development of transformational technology within the medical, consumer, and military sectors BELGIUM – Ghent, 15 May 2023 – Indigo Diabetes N.V. (‘Indigo’ or the...
by Indigo | May 5, 2023 | 2023, News
Indigo Diabetes nv. has completed the Hephaestus Research Project. In September 2021, Indigo received a €3 million Hephaestus grant from VLAIO, the Flanders organisation for Innovation & Entrepreneurship, to conduct research into the high-volume production of...
by Indigo | Feb 21, 2023 | 2023, News, Press
BELGIUM – Ghent, 21 February 2023: Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of Continuous Metabolite Monitoring (CMM®) devices utilising proprietary nanophotonics technology, today announces that that an abstract featuring its CMM®...
by Indigo | Jan 4, 2023 | 2023, News, Press
SHINE clinical trial enrolment progressing well following positive results from the GLOW early feasibility trial Several key senior appointments made in Europe and the US, reflecting the growth and evolution from an early stage to a development stage...
